IR@PKUHSC  > 北京大学第一临床医学院  > 心血管内科
学科主题临床医学
Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study)
Liu, Peng; Jiang, Jie; Li, Jianping; Hong, Tao; Zhang, Yan; Yu, Ronghui; Jia, Jia; Huo, Yong
关键词percutaneous coronary intervention myocardial infarction stent statins
刊名CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
2012-05-01
DOI10.1002/ccd.23171
79期:6页:967-971
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems
研究领域[WOS]Cardiovascular System & Cardiology
关键词[WOS]PERIPROCEDURAL MYOCARDIAL-INFARCTION ; C-REACTIVE PROTEIN ; RANDOMIZED-TRIAL ; STENT IMPLANTATION ; UNSTABLE ANGINA ; ATORVASTATIN ; ATHEROSCLEROSIS ; INFLAMMATION ; ANGIOPLASTY ; REDUCTION
英文摘要

Background: Myocardial necrosis is related to higher incidence of cardiovascular events and higher mortality rates during follow-up. Statins have been demonstrated to lower the risk of periprocedural myocardial infarction. The aim of this study is to evaluate the safety and efficacy of intensive statin therapy and the long-term outcome of patients in the Asian population. Study design: Approximately 1,100 patients with stable angina or non-ST elevation acute coronary syndrome undergoing selective percutaneous coronary intervention (PCI) are enrolled in this study. Patients are randomized either to the experimental group (80 mg atorvastatin 80 mg/day x 2 days before and 40 mg/day x 30 days after PCI) or to the control group (usual care). Creatine kinase-MB (CK-MB), troponin I (cTnI), and serum creatine are measured at 24 hours after the procedure. The total follow-up period is 6 months. The primary objective is to evaluate the efficacy of intensive atorvastatin treatment compared with usual care in reducing 30-day primary cardiovascular endpoints in patients undergoing selective PCI. Secondary endpoints are changes in myocardial biomarkers (cTnI, CK-MB) and hs-CRP, CIN morbidity, 6-month clinical outcomes, and safety. Conclusion: The result of the ISCAP study will provide important evidence on the efficacy and safety of periprocedural serial intensive statin treatment in Asian patients with coronary artery disease undergoing selective PCI. (C) 2011 Wiley Periodicals, Inc.

语种英语
WOS记录号WOS:000302907900023
资助机构China Medical Foundation
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67918
专题北京大学第一临床医学院_心血管内科
北京大学第一临床医学院_科研处
作者单位Peking Univ, Dept Cardiol, Hosp 1, Beijing 100034, Peoples R China
推荐引用方式
GB/T 7714
Liu, Peng,Jiang, Jie,Li, Jianping,et al. Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study)[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS,2012,79(6):967-971.
APA Liu, Peng.,Jiang, Jie.,Li, Jianping.,Hong, Tao.,Zhang, Yan.,...&Huo, Yong.(2012).Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study).CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS,79(6),967-971.
MLA Liu, Peng,et al."Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study)".CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS 79.6(2012):967-971.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, Peng]的文章
[Jiang, Jie]的文章
[Li, Jianping]的文章
百度学术
百度学术中相似的文章
[Liu, Peng]的文章
[Jiang, Jie]的文章
[Li, Jianping]的文章
必应学术
必应学术中相似的文章
[Liu, Peng]的文章
[Jiang, Jie]的文章
[Li, Jianping]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。